2m 2m 2m 2m 2m 2m 2m
EQUILLIUM (EQ)
NASDAQ
$2.34+$0.02 (+1.08%)
Price as of Aug 21, 2026 7:37 PM EDT- $146.5MMarket Cap
- 21.58%1-Year Change
- BiotechnologyIndustry
EQUILLIUM (EQ)
$2.34+$0.02 (+1.08%)
EQ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.31 | ||
Change | +$0.04 (+1.76%) | ||
Open | $2.30 | ||
High | $2.46 | ||
Low | $2.24 | ||
Previous Close | $2.27 | ||
Volume | 557,353 | ||
30-Day Average Volume | 508,204 | ||
1-Week Change | -2.12% | ||
1-Month Change | -12.17% | ||
1-Year Change | 21.58% | ||
3-Year Change | 174.35% | ||
5-Year Change | -52.27% | ||
Fundamentals | |||
Shares Outstanding | 63.4M | ||
Total Assets | $58.7M | ||
Market Cap | $146.5M | ||
Enterprise Value | $89.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.7M | ||
Net Working Capital | $55.5M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -58 | ||
PEG | -2 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 06/12/2009 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue